20 Aug AvéULTRA: New and Improved Avemar Now Available
American BioSciences Inc., exclusive U.S. distributor of Avemar Fermented Wheat Germ Extract, has been granted the license to manufacture Avemar in the United States by its inventor and patent holder, Dr. Mate Hidvegi. Utilizing new manufacturing technology, which more precisely controls processing time and temperatures, Dr. Hidvegi supervised the production of a new and improved wheat germ extract for American BioSciences, called AvéULTRA. The result is a superior product with superior results.
New and Improved
Extensive independent scientific evaluations confirm that this new manufacturing technique produces a better product as compared to the original version of Avemar. These techniques have been verified by multiple scientific evaluation and they include:
- HPLC (high pressure liquid chromatography) and MS (mass spectrometry) analyses show the two products have similar “chemical finger prints,” and biological assays show superior results for the American BioSciences product.
- In vitro (cell line assays) conducted at Georgetown University, Washington, DC and the Medical University of Vienna, Austria, showed that on all cell lines studied, the American BioSciences product was significantly more effective than the original Avemar.
- In vivo research conducted at the National Institute of Oncology in Budapest, Hungary, the American BioSciences product resulted in significantly superior results.
This data is being prepared for publication in a peer-reviewed medical journal.
According to Dr. Hidvegi, these outstanding results would be expected, since fermented wheat germ extract contains several heat-sensitive compounds which are better preserved by the low temperature technology of the American BioSciences’ manufacturing process.
American BioSciences shares the desire and commitment of Dr. Hidvegi to provide the most effective fermented wheat germ extract that will help people in need all over the world.
Helping People Globally
Other manufacturers of less effective versions of fermented wheat germ extract continue to spread false statements regarding potency and even claims of inventorship. However, American BioSciences and Dr. Hidvegi are moving forward to present this new formula to doctors and consumers in an effort to help people all over the world.
Consumers and physicians with questions relating to the new AvéULTRA are invited to contact American BioSciences president David Wales directly at (888) 884-7770.